B-intervention	0	9	Telephone
I-intervention	10	20	counseling
O	21	24	and
O	25	35	attendance
O	36	38	in
O	39	40	a
O	41	49	national
O	50	61	mammography
O	61	62	-
O	62	71	screening
O	72	79	program
O	80	81	a
O	82	92	randomized
O	93	103	controlled
O	104	109	trial
O	109	110	.

O	111	113	In
B-location	114	121	Germany
O	121	122	,
O	123	124	a
O	125	136	mammography
O	136	137	-
O	137	146	screening
O	147	154	program
O	155	156	(
O	156	159	MSP
O	159	160	)
O	161	164	was
O	165	176	implemented
O	177	179	on
O	180	181	a
O	182	190	national
O	191	196	level
O	196	197	.

O	198	200	It
O	201	209	complies
O	210	214	with
O	215	218	all
O	219	227	criteria
O	228	230	of
O	231	234	the
O	235	243	European
O	244	254	guidelines
O	255	258	for
O	259	266	quality
O	267	276	assurance
O	277	279	in
O	280	289	screening
O	290	301	mammography
O	301	302	;
O	303	310	however
O	310	311	,
O	312	315	the
O	316	326	attendance
O	327	331	rate
O	332	334	is
O	335	337	54
O	337	338	%
O	338	339	,
O	340	347	falling
O	348	353	short
O	354	356	of
O	357	360	the
O	361	367	target
O	368	378	attendance
O	379	383	rate
O	384	386	of
O	387	389	70
O	389	390	%
O	390	391	.

O	392	395	The
O	396	399	aim
O	400	402	of
O	403	407	this
O	408	413	study
O	414	417	was
O	418	420	to
O	421	432	investigate
O	433	440	whether
O	441	451	additional
O	452	461	telephone
O	462	472	counseling
O	473	481	improves
O	482	492	attendance
O	493	498	among
O	499	512	nonresponders
O	513	516	and
O	517	520	the
O	521	526	level
O	527	529	of
O	530	542	satisfaction
O	543	547	with
O	548	557	telephone
O	558	568	counseling
O	568	569	.

O	570	572	In
O	573	574	a
O	575	586	prospective
O	587	590	RCT
O	590	591	,
O	592	597	women
O	598	608	identified
O	609	611	as
O	612	625	nonresponders
O	626	628	in
O	629	632	the
O	633	636	MSP
O	637	641	were
O	642	652	randomized
O	653	655	to
O	656	657	a
B-control	658	665	control
I-control	666	671	group
O	672	676	that
O	677	685	received
O	686	693	written
O	694	703	reminders
O	704	706	or
O	707	709	to
O	710	712	an
O	713	725	intervention
O	726	731	group
O	732	736	that
O	737	749	additionally
O	750	758	received
O	759	768	telephone
O	769	779	counseling
O	779	780	.

O	781	783	In
O	784	785	a
O	786	792	follow
O	792	793	-
O	793	795	up
O	795	796	,
O	797	798	a
O	799	805	subset
O	806	808	of
O	809	812	the
O	813	825	intervention
O	826	831	group
O	832	835	was
O	836	845	contacted
O	846	848	by
O	849	858	telephone
O	859	868	regarding
O	869	874	their
O	875	887	satisfaction
O	888	892	with
O	893	902	telephone
O	903	913	counseling
O	913	914	.

O	915	917	In
O	918	922	2008
O	922	923	,
O	924	925	a
O	926	931	total
O	932	934	of
B-total-participants	935	939	5477
O	940	945	women
O	946	950	aged
B-age	951	953	50
I-age	953	954	-
I-age	954	956	69
I-age	957	962	years
O	963	966	who
O	967	971	were
O	972	980	eligible
O	981	984	for
O	985	988	the
O	989	995	German
O	996	999	MSP
O	1000	1003	but
O	1004	1007	had
O	1008	1011	not
O	1012	1024	participated
O	1025	1027	up
O	1028	1030	to
O	1031	1032	6
O	1033	1038	weeks
O	1039	1044	after
O	1045	1048	the
O	1049	1054	first
O	1055	1065	invitation
O	1066	1070	were
O	1071	1079	included
O	1080	1082	in
O	1083	1086	the
O	1087	1092	study
O	1092	1093	.

O	1094	1104	Individual
O	1105	1114	telephone
O	1115	1125	counseling
O	1126	1135	consisted
O	1136	1138	of
O	1139	1147	scripted
O	1148	1153	calls
O	1154	1158	from
O	1159	1160	a
O	1161	1168	trained
O	1169	1178	counselor
O	1179	1182	who
O	1183	1191	provided
O	1192	1203	information
O	1204	1206	on
O	1207	1210	MSP
O	1211	1214	and
O	1215	1223	answered
O	1224	1227	the
O	1228	1233	woman
O	1233	1234	'
O	1234	1235	s
O	1236	1245	questions
O	1245	1246	.

O	1247	1253	Report
O	1254	1256	of
O	1257	1268	mammography
O	1269	1272	use
O	1273	1281	provided
O	1282	1284	by
O	1285	1288	the
O	1289	1298	screening
O	1299	1303	unit
O	1304	1305	3
O	1306	1312	months
O	1313	1318	after
O	1319	1322	the
O	1323	1331	reminder
O	1332	1335	was
O	1336	1340	sent
O	1340	1341	.

O	1342	1350	Analysis
O	1351	1354	was
O	1355	1364	conducted
O	1365	1367	in
O	1368	1372	2009
O	1372	1373	.

O	1374	1384	Comparison
O	1385	1387	of
O	1388	1397	screening
O	1398	1408	attendance
O	1409	1417	revealed
O	1418	1419	a
O	1420	1433	significantly
O	1434	1440	higher
B-outcome	1441	1451	attendance
I-outcome	1452	1456	rate
O	1457	1459	in
O	1460	1463	the
O	1464	1476	intervention
O	1477	1482	group
O	1483	1491	compared
O	1492	1496	with
O	1497	1505	controls
O	1506	1507	(
B-iv-bin-percent	1507	1509	29
I-iv-bin-percent	1509	1510	.
I-iv-bin-percent	1510	1511	7
I-iv-bin-percent	1511	1512	%
O	1513	1515	vs
B-cv-bin-percent	1516	1518	26
I-cv-bin-percent	1518	1519	.
I-cv-bin-percent	1519	1520	1
I-cv-bin-percent	1520	1521	%
O	1521	1522	,
O	1523	1524	p
O	1524	1525	=
O	1525	1526	0
O	1526	1527	.
O	1527	1531	0035
O	1531	1532	)
O	1532	1533	.

O	1534	1538	When
O	1539	1543	only
O	1544	1549	women
O	1550	1553	for
O	1554	1558	whom
O	1559	1568	telephone
O	1569	1576	numbers
O	1577	1581	were
O	1582	1591	available
O	1592	1596	were
O	1597	1605	analyzed
O	1605	1606	,
B-outcome	1607	1617	attendance
O	1618	1621	was
O	1622	1626	even
O	1627	1633	better
O	1634	1635	(
B-iv-bin-percent	1635	1637	35
I-iv-bin-percent	1637	1638	.
I-iv-bin-percent	1638	1639	5
I-iv-bin-percent	1639	1640	%
O	1641	1643	vs
B-cv-bin-percent	1644	1646	29
I-cv-bin-percent	1646	1647	.
I-cv-bin-percent	1647	1648	7
I-cv-bin-percent	1648	1649	%
O	1649	1650	,
O	1651	1652	p
O	1652	1653	=
O	1653	1654	0
O	1654	1655	.
O	1655	1659	0004
O	1659	1660	)
O	1660	1661	.

O	1662	1664	In
O	1665	1668	the
O	1669	1675	follow
O	1675	1676	-
O	1676	1678	up
O	1678	1679	,
B-total-participants	1680	1683	278
O	1684	1686	of
O	1687	1690	404
O	1691	1696	women
O	1697	1701	were
O	1702	1710	actually
O	1711	1719	surveyed
O	1719	1720	.

O	1721	1723	Of
O	1724	1729	those
O	1729	1730	,
O	1731	1733	33
O	1733	1734	%
O	1735	1741	stated
O	1742	1746	that
O	1747	1756	telephone
O	1757	1767	counseling
O	1768	1771	had
B-outcome	1772	1782	influenced
I-outcome	1783	1788	their
I-outcome	1789	1797	decision
O	1797	1798	,
O	1799	1801	56
O	1801	1802	%
O	1803	1809	stated
O	1810	1814	that
O	1815	1819	they
O	1820	1823	had
B-outcome	1824	1833	undergone
I-outcome	1834	1843	screening
I-outcome	1844	1855	mammography
O	1855	1856	,
O	1857	1860	and
O	1861	1863	77
O	1863	1864	%
O	1865	1871	agreed
O	1872	1876	that
O	1877	1885	personal
O	1886	1895	telephone
O	1896	1906	counseling
O	1907	1913	should
O	1914	1916	be
O	1917	1921	used
O	1922	1931	routinely
O	1932	1934	to
O	1935	1944	encourage
O	1945	1958	nonresponders
O	1959	1961	to
O	1962	1964	go
O	1965	1968	for
B-outcome	1969	1978	screening
O	1978	1979	.

O	1980	1990	Individual
O	1991	2000	telephone
O	2001	2011	counseling
O	2012	2015	for
O	2016	2029	nonresponders
O	2030	2032	to
O	2033	2034	a
O	2035	2043	national
O	2044	2051	program
O	2052	2055	for
O	2056	2062	breast
O	2063	2069	cancer
O	2070	2079	screening
O	2080	2083	was
O	2084	2088	well
O	2089	2097	accepted
O	2098	2100	by
O	2101	2113	participants
O	2114	2117	and
O	2118	2127	effective
O	2127	2128	.

O	2129	2133	This
O	2134	2139	study
O	2140	2142	is
O	2143	2153	registered
O	2154	2156	at
O	2157	2160	the
O	2161	2171	Australian
O	2172	2175	New
O	2176	2183	Zealand
O	2184	2192	Clinical
O	2193	2199	Trials
O	2200	2208	Registry
O	2209	2228	ACTRN12611000645954
O	2228	2229	.
